A Prospective Evaluation of the Treatment of Primary or Metastatic Liver Carcinoma with Hepatic Arterial Infusion Chemotherapy

References

• Ackerman N. B. Experimental studies on the role of the portal circulation in hepatic tumour vascularity. Cancer 1986; 58: 1653–7
   PubMedGoogle Scholar
• Ensminger W. D., Rosowsky A., Raso V., et al. A clinical pharmacological evaluation of hepatic arterial infusion of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 1978; 38: 3784–92
   PubMed Web of Science ®Google Scholar
• Goldberg J. A., Kerr D. J., Wilmott N., McKillop J. H., McArdle J. S. Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg 1990; 77: 1238–40
   PubMed Web of Science ®Google Scholar
• Taguchi T., Ogawa N., Bunke B., Nilsson B. DSM Study Group. The use of degradable starch microspheres (spherex) with intra-arterial chemotherapy for the treatment of primary and secondary liver tumours-results of a phase III clinical trial. Reg Cancer Treat 1992; 4: 161–5
   Google Scholar
• Konno T., Kai Y., Yamashita R., Nagamitsu A., Kimura M. Targeted chemotherapy for unresectable primary and metastatic liver cancer. Acta Oncol 1994; 33: 133–7
   PubMed Web of Science ®Google Scholar
• Balch C. M., Vrist M. M., Soong S. J., McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983; 198: 567–73
   PubMed Web of Science ®Google Scholar
• WHO Handbook for Reporting Results of Cancer Treatment. Offset Publication No. 48. WHO, Geneva 1979
   Google Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Chang A. E., Schneider P. D., Sugarbaker H., Simpson C., Culnane M., Steinberg S. M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685–93
   PubMed Web of Science ®Google Scholar
• Hohn D. C., Stagg R. J., Friedman M. A., et al. A randomized trial for continuous intravenous versus hepatic intra-arterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 1989; 7: 1646–54
   PubMed Web of Science ®Google Scholar
• Takats P. G., Kerr D. J., Poole C. J., Warren H. W., McArdle C. S. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994; 69: 372–8
   PubMedGoogle Scholar
• Groupe Francophone d'Etude et de Traitement du Carcinome Hepatocellulaire. Treatment of unresectable hepatocellular carcinoma by Iipiodol-targeted transcatheter arterial chemoembolization. A multicenter randomized trial (Abstract). Hepatology 1993; 18: 58A.
   Google Scholar
• Hidalgo O. F., Rebollo J., Vieitez J. M., et al. Intra-arterial hepatic treatment with carboplatin and 5-fluorouracil in metastases from colorectal carcinoma. Am J Clin Oncol 1993; 16: 30–3
   PubMedGoogle Scholar
• Makela J., Tikkakoski T., Leinonen A., Siniluoto T., Karthumen A., Kairalunen A. Superselective intra-arterial chemotherapy with mitomycin C in hepatic neoplasms. Eur J Surg Oncol 1993; 19: 348–54
   PubMedGoogle Scholar
• Wu C. C., Ho Y. Z., Lin Ho W., Wu T. C., Liu T. J., P'eng KP. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82: 122–6
   PubMed Web of Science ®Google Scholar
• Bruix J., Castells A., Motanya X., et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology 1994; 20: 643–50
   PubMed Web of Science ®Google Scholar
• Paquet K. J., Kalk J. F., Cuan-Orozco F., Siemens F., Koussouris P., Mercado M. A. Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced primary hepatocellular carcinoma. Eur J Surg Oncol 1992; 18: 156–61
   PubMedGoogle Scholar
• Rougier P., Laplanche A., Huguier M., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112–20
   PubMed Web of Science ®Google Scholar
• Yonemura Y., Matuki N., Sakuma H., et al. Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases. Surg Today 1992; 22: 253–9
   PubMedGoogle Scholar
• Moriya Y., Sugihara K., Hojo K., Makuuchi M. Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. Eur J Surg Oncol 1991; 17: 519–25
   PubMed Web of Science ®Google Scholar